XML 142 R2.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Assets and Liabilities - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
ASSETS    
Investments at fair value: $ 599,929 [1] $ 71,758 [2]
Cash, cash equivalents and restricted cash 3,211 19,486
Interest receivable for non-controlled/non-affiliated investments 584 356
Deferred financing costs 2,618 335
Deferred offering costs 1,945 0
Unrealized appreciation on foreign currency forward contracts 9 0
Receivable for investments sold 52 65
Total assets 608,348 92,000
LIABILITIES    
Debt 303,530 31,000
Payable for investments purchased 0 10,894
Interest payable 98 103
Board of Trustees fee payable 0 92
Accrued expenses and other liabilities 3,229 216
Total liabilities 306,857 42,305
Commitments and contingencies  
NET ASSETS    
Common shares 114 20
Additional paid in capital 298,712 49,980
Distributable earnings (loss) 2,665 (305)
Total net assets 301,491 49,695
Total liabilities and net assets $ 608,348 $ 92,000
Net asset value per share (in dollars per share) $ 26.33 $ 24.85
[1] Unless otherwise indicated, issuers of debt investments held by the Company (which such term “Company” shall include the Company’s subsidiaries for purposes of this Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated.
[2] Unless otherwise indicated, issuers of debt investments held by the Company (which such term “Company” shall include the Company’s subsidiaries for purposes of this Schedule of Investments) are denominated in dollars. All debt investments are income producing unless otherwise indicated.